These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12713009)

  • 1. [Selection of antihypertensive agents with view of organ protection].
    Tsuchihashi T
    Fukuoka Igaku Zasshi; 2002 Dec; 93(12):255-8. PubMed ID: 12713009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of stroke].
    Uchiyama S; Nakamura T; Terashi H
    No To Shinkei; 2004 Nov; 56(11):907-19. PubMed ID: 15678947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of hypertension in patients with cerebrovascular disease].
    Tsuchihashi T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():460-4. PubMed ID: 15171416
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertension therapy in practice test. Calcium antagonist receives good marks].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2005 Jan; 147(1-2):51. PubMed ID: 15704573
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk factors to be considered at the beginning of antihypertensive therapy in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2004 May; 145(18):949-56. PubMed ID: 15188641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS inhibition in hypertension.
    Ibrahim MM
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in diabetes.
    Vijan S
    Clin Evid; 2005 Dec; (14):491-500. PubMed ID: 16620417
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment for hypertension in patients with renal diseases].
    Nakamura S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():452-9. PubMed ID: 15179937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evidence-based usefulness of Ca antagonists and ACEIs and ARBs for the primary and secondary prevention of major cardiovascular and renal events in patients with hypertension].
    Fujino T; Hasebe N; Kikuchi K
    Clin Calcium; 2005 Oct; 15(10):1695-708. PubMed ID: 16199917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recent fixed-dose combination therapies in the management of hypertension.
    Khanna A; Lefkowitz L; White WB
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):477-83. PubMed ID: 18695388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the patient with diabetes mellitus and risk of nephropathy: what do we know, and what do we need to learn?
    Hollenberg NK
    Arch Intern Med; 2004 Jan; 164(2):125-30. PubMed ID: 14744834
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation and management of hypertension in children and adolescents (part two): evaluation and management.
    Cromwell PF; Munn N; Zolkowski-Wynne J
    J Pediatr Health Care; 2005; 19(5):309-13. PubMed ID: 16202839
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Lyle PA; Tershakovec AM; Devereux RB; Oparil S; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Wedel H
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):729-45. PubMed ID: 16262560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.